Information about Dexafas
My details
*
*
*

Dexafas (SRL)

BE 0822.654.129

Drie Eikenstraat 23, 3620 Lanaken

Company information

Status
Active

Enterprise number

BE0822.654.129

VAT liability
No
Established
26-01-2010
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Other information service activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Dexafas

2024 2023 2022 2021
Profit/Loss € -12,714 6 % € -13,542 6 % € -14,442 19 % € -17,731
Equity € 298,166 -4 % € 310,880 -4 % € 324,422 -4 % € 338,864
Gross margin € 39,070 12 % € 34,943 16 % € 30,070 10 % € 27,391

Publications from Dexafas

Date Publication
19-09-2025 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Miscellaneous - Resignations - Appointments (NL)
02-03-2010 Resignations - Appointments (NL)
08-02-2010 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the enterprise number of Dexafas?
The enterprise number of Dexafas is BE 0822.654.129.
Wat is the PEPPOL ID of Dexafas?
The PEPPOL ID of Dexafas is 0208:0822654129. Log in or start a free trial to see the full overview.
When was Dexafas founded?
Dexafas was founded on 26-01-2010.
What is the address of Dexafas?
The current registered office of Dexafas is located at Drie Eikenstraat 23, 3620 Lanaken.
When was the last time Dexafas filed their annual financial statements?
The most recent financial statements of Dexafas were filed on 27-06-2025.
How many employees does Dexafas have?
There are currently no employees working at Dexafas or no workforce information is available.
What is the annual turnover of Dexafas?
At the time of its most recent financial statements, Dexafas did not publish any turnover figures. Dexafas reported a gross margin of €39,069.91.

Sources